Uricip D 0.4mg/0.5mg Tablet MR

Overview Uricip D 0.4mg/0.5mg Tablet MR

Prostaduo 0.4mg/0.5mg Modified-Release tablets combine two active ingredients with distinct mechanisms to alleviate symptoms of benign prostatic hyperplasia (BPH) in adult males. This treatment offers relief from urinary difficulties, such as frequent urination or hesitancy. It does not prevent prostate cancer. Prostaduo 0.4mg/0.5mg MR tablets can be taken with or without food, but consistent daily timing is crucial. Dosage is determined by your physician. For optimal symptom management, consistent daily intake is recommended, even when feeling well. Significant symptom improvement may take up to four weeks; continued regular use is essential. Consult your doctor if symptoms worsen or show no improvement after four weeks. Common side effects include erectile dysfunction, reduced sex drive, breast tenderness, and ejaculatory problems. Report persistent or concerning side effects to your doctor. Dizziness or drowsiness may also occur, particularly at the treatment initiation. Your doctor has prescribed this medication because the potential benefits outweigh the risks. Prostaduo 0.4mg/0.5mg MR tablets are contraindicated in women and children. Inform your physician of any pre-existing conditions, such as low blood pressure, liver or kidney impairment, before commencing treatment, as it may not be appropriate. Drug interactions are possible; disclose all other medications to your doctor. Condom use during sexual activity is advisable if your partner is, or could be, pregnant. Regular blood pressure monitoring may be recommended. Alcohol consumption should be avoided due to the increased risk of dizziness.

Primary Ingredients of Uricip D 0.4mg/0.5mg Tablet MR

No information provided. A rephrased version cannot be created.

Uses of Uricip D 0.4mg/0.5mg Tablet MR

Managing benign prostatic hyperplasia

Major Benefits of Uricip D 0.4mg/0.5mg Tablet MR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Uricip D 0.4mg/0.5mg Modified-Release Tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Uricip D 0.4mg/0.5mg Tablet MR:

• Impotence
• Decreased libido
• Ejaculation disorder
• Orthostatic hypotension (sudden lowering of blood pressure on standing)
• Breast enlargement in male
• Breast tenderness in male
• Dizziness

How to use Uricip D 0.4mg/0.5mg Tablet MR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Uricip D 0.4mg/0.5mg Modified-Release Tablets may be consumed with or without food, though consistent timing is recommended.

How Uricip D 0.4mg/0.5mg Tablet MR works:

Uricip D 0.4mg/0.5mg Modified-Release tablets combine tamsulosin and dutasteride to alleviate benign prostatic hyperplasia symptoms. Tamsulosin, an alpha-adrenergic antagonist, eases urination by relaxing prostate and bladder neck muscles. Dutasteride, a 5α-reductase inhibitor, reduces prostate size by lowering levels of a hormone that stimulates prostate growth.

What if you forget to take Uricip D 0.4mg/0.5mg Tablet MR :

Should you forget to take your Uricip D 0.4mg/0.5mg MR Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.